Skip to main content
Erschienen in: World Journal of Urology 4/2020

08.06.2019 | Original Article

EMS Lithoclast Trilogy™: an effective single-probe dual-energy lithotripter for mini and standard PCNL

verfasst von: Ravindra B. Sabnis, Sudharsan S. Balaji, Parag L. Sonawane, Rohan Sharma, Mohankumar Vijayakumar, Abhishek G. Singh, Arvind P. Ganpule, Mahesh R. Desai

Erschienen in: World Journal of Urology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Several energy sources are available to clear stones during PCNL. Required improvements are faster stone clearance, optimized suction and ease of use while maintaining high patient safety standard. EMS LithoClast® Trilogy, is the first device combining electromagnetic impactor with ultrasonic energy and suction, all-in-one probe. Animal studies and in vitro phantom stone studies have proven safety and efficacy of this device. We aim to study safety and clinical efficacy of Trilogy in our patients.

Methods

31 patients with renal stones were included. Amplatz sheath sizes/Trilogy probe size was 22–28 Fr/10.2 Fr for standard PNL (n = 20) and 15 Fr./5.7 Fr for mini PNL access (n = 11). Analysis was done with respect to demography, stone characteristics, operation duration (total time and lithotripter activation time), post op Hb drop, clearance rate and adverse events. Stone area/volume was calculated based on CT using 3D doctor. Efficacy was determined by stone volume clearance rate (mm3/min).

Results

Male:female ratio was 6:5 and 16:4 for mini (MPNL)/standard PNL (SPNL). Stone densities were 1229 ± 206 vs. 1168 ± 344 HU (MPNL vs. SPNL). Mean stone volumes were 3776.1 ± 2132 mm3 for MPNL and 7096 ± 6441 for SPNL. Mean stone volume clearance ratios were 370.5 ± 171 mm3/min and 590.7 ± 250mm3/min for MPNL and SPNL, respectively. Hb drop was 1.24 ± 0.64 g/dL (MPNL) and 1.23 ± 0.89gm/dL (SPNL). Total procedure time/lithotripter activation time was 53.4 ± 23.8/14.7 ± 12.4 min for MPNL and 65.2 ± 23.5/12.0 ± 8.9 for SPNL. Immediate post-operative/1 month stone clearance rates were 93%/96% with one clinically insignificant residual fragment (< 3 mm) and no necessity for auxiliary procedures. No device failure occured and three Clavien grade I and one grade II complications were observed.

Conclusion

Swiss LithoClast® Trilogy provides fast stone clearance in standard/mini-PCNL procedures. Ease of use, high tissue safety and optimized suction that avoids fragment blockings are other key features.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ganpule AP, Desai MR (2012) What’s new in percutaneous nephrolithotomy. Arab J Urol 10(3):317–323CrossRef Ganpule AP, Desai MR (2012) What’s new in percutaneous nephrolithotomy. Arab J Urol 10(3):317–323CrossRef
2.
Zurück zum Zitat Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69(3):475–482CrossRef Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69(3):475–482CrossRef
3.
Zurück zum Zitat Michel MS, Honeck P, Alken P (2008) New endourologic technology for simultaneous holmium: YAG laser lithotripsy and fragment evacuation for PCNL: ex-vivo comparison to standard ultrasonic lithotripsy. J Endourol 22(7):1537–1540CrossRef Michel MS, Honeck P, Alken P (2008) New endourologic technology for simultaneous holmium: YAG laser lithotripsy and fragment evacuation for PCNL: ex-vivo comparison to standard ultrasonic lithotripsy. J Endourol 22(7):1537–1540CrossRef
4.
Zurück zum Zitat Piergiovanni M, Desgrandchamps F, Cochand-priollet BÉ, Janssen T, Colomer S, Teillac P, Led uc AL (1994) Ureteral and bladder lesions after ballistic, ultrasonic, electrohydraulic, or laser lithotripsy. J Endourol 8(4):293–299CrossRef Piergiovanni M, Desgrandchamps F, Cochand-priollet BÉ, Janssen T, Colomer S, Teillac P, Led uc AL (1994) Ureteral and bladder lesions after ballistic, ultrasonic, electrohydraulic, or laser lithotripsy. J Endourol 8(4):293–299CrossRef
5.
Zurück zum Zitat Hofmann R, Pickl U, Hartung R (1996) The Lithoclast and Lithoclast Master—an experimental and clinical comparison. J Endourol 10:S119 Hofmann R, Pickl U, Hartung R (1996) The Lithoclast and Lithoclast Master—an experimental and clinical comparison. J Endourol 10:S119
6.
Zurück zum Zitat Hofmann R, Pickl U, Schwarzer JU, Hartung R (1994) Mechanical vs. laser lithotripsy for ureteral calculi. J Urol 151(151):203A Hofmann R, Pickl U, Schwarzer JU, Hartung R (1994) Mechanical vs. laser lithotripsy for ureteral calculi. J Urol 151(151):203A
7.
Zurück zum Zitat Cho C, Yu JH, Sung LH, Chung JY, Noh CH (2010) Comparison of percutaneous nephrolithotomy using pneumatic lithotripsy (lithoclast®) alone or in combination with ultrasonic lithotripsy. Korean J Urol 51(11):783–787CrossRef Cho C, Yu JH, Sung LH, Chung JY, Noh CH (2010) Comparison of percutaneous nephrolithotomy using pneumatic lithotripsy (lithoclast®) alone or in combination with ultrasonic lithotripsy. Korean J Urol 51(11):783–787CrossRef
8.
Zurück zum Zitat York NE, Borofsky MS, Chew BH, Dauw CA, Paterson RF, Denstedt JD, Razvi H, Nadler RB, Humphreys MR, Preminger GM, Nakada SY (2017) Randomized controlled trial comparing three different modalities of lithotrites for intracorporeal lithotripsy in percutaneous nephrolithotomy. J Endourol 31(11):1145–1151CrossRef York NE, Borofsky MS, Chew BH, Dauw CA, Paterson RF, Denstedt JD, Razvi H, Nadler RB, Humphreys MR, Preminger GM, Nakada SY (2017) Randomized controlled trial comparing three different modalities of lithotrites for intracorporeal lithotripsy in percutaneous nephrolithotomy. J Endourol 31(11):1145–1151CrossRef
9.
Zurück zum Zitat Hofmann R, Olbert P, Weber J, Wille S, Varga Z (2002) Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy. BJU Int 90(1):16–19CrossRef Hofmann R, Olbert P, Weber J, Wille S, Varga Z (2002) Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy. BJU Int 90(1):16–19CrossRef
10.
Zurück zum Zitat Jou YC, Shen CH, Cheng MC, Chen PC (2007) High-power holmium: yttrium–aluminum–garnet laser for percutaneous treatment of large renal stones. Urology 69(1):22–25CrossRef Jou YC, Shen CH, Cheng MC, Chen PC (2007) High-power holmium: yttrium–aluminum–garnet laser for percutaneous treatment of large renal stones. Urology 69(1):22–25CrossRef
11.
Zurück zum Zitat Kronenberg P, Traxer O (2015) Update on lasers in urology 2014: current assessment on holmium: yttrium–aluminum–garnet (Ho:YAG) laser lithotripter settings and laser fibers. World J Urol 33(4):463–469CrossRef Kronenberg P, Traxer O (2015) Update on lasers in urology 2014: current assessment on holmium: yttrium–aluminum–garnet (Ho:YAG) laser lithotripter settings and laser fibers. World J Urol 33(4):463–469CrossRef
12.
Zurück zum Zitat Kronenberg P, Somani B (2018) Advances in lasers for the treatment of stones—a systematic review. Curr Urol Rep 19(6):45CrossRef Kronenberg P, Somani B (2018) Advances in lasers for the treatment of stones—a systematic review. Curr Urol Rep 19(6):45CrossRef
13.
Zurück zum Zitat Althunayan AM, Elkoushy MA, Elhilali MM, Andonian S (2014) Adverse events resulting from lasers used in urology. J Endourol 28(2):256–260CrossRef Althunayan AM, Elkoushy MA, Elhilali MM, Andonian S (2014) Adverse events resulting from lasers used in urology. J Endourol 28(2):256–260CrossRef
14.
Zurück zum Zitat Pugh JW, Canales BK (2010) New instrumentation in percutaneous nephrolithotomy. Indian J Urol J Urol Soc India 26(3):389CrossRef Pugh JW, Canales BK (2010) New instrumentation in percutaneous nephrolithotomy. Indian J Urol J Urol Soc India 26(3):389CrossRef
15.
Zurück zum Zitat Chew BH, Matteliano AA, de los Reyes T, Lipkin ME, Paterson RF, Lange D (2017) Benchtop and initial clinical evaluation of the ShockPulse stone eliminator in percutaneous nephrolithotomy. J Endourol 31(2):191–197CrossRef Chew BH, Matteliano AA, de los Reyes T, Lipkin ME, Paterson RF, Lange D (2017) Benchtop and initial clinical evaluation of the ShockPulse stone eliminator in percutaneous nephrolithotomy. J Endourol 31(2):191–197CrossRef
16.
Zurück zum Zitat Carlos EC, Wollin DA, Winship BB, Jiang R, Radvak D, Chew BH, Gustafson MR, Simmons WN, Zhong P, Preminger GM, Lipkin ME (2018) In vitro comparison of a novel single probe dual-energy lithotripter to current devices. J Endourol 32(6):534–540CrossRef Carlos EC, Wollin DA, Winship BB, Jiang R, Radvak D, Chew BH, Gustafson MR, Simmons WN, Zhong P, Preminger GM, Lipkin ME (2018) In vitro comparison of a novel single probe dual-energy lithotripter to current devices. J Endourol 32(6):534–540CrossRef
17.
Zurück zum Zitat Khoder WY, Bader MJ, Haseke N, Stief CG, Baumgartl M, Pongratz T, Sroka R (2014) In vitro comparisons of retropulsion and fragmentation efficacy of 2 cordless, handheld pneumatic and electromechanical lithotripsy devices. Urology 83(4):726–731CrossRef Khoder WY, Bader MJ, Haseke N, Stief CG, Baumgartl M, Pongratz T, Sroka R (2014) In vitro comparisons of retropulsion and fragmentation efficacy of 2 cordless, handheld pneumatic and electromechanical lithotripsy devices. Urology 83(4):726–731CrossRef
18.
Zurück zum Zitat Denstedt JD, Razvi HA, Rowe E, Grignon DJ, Eberwein PM (1995) Investigation of the tissue effects of a new device for intracorporeal lithotripsy—the Swiss Lithoclast. J Urol 153(2):535–537CrossRef Denstedt JD, Razvi HA, Rowe E, Grignon DJ, Eberwein PM (1995) Investigation of the tissue effects of a new device for intracorporeal lithotripsy—the Swiss Lithoclast. J Urol 153(2):535–537CrossRef
Metadaten
Titel
EMS Lithoclast Trilogy™: an effective single-probe dual-energy lithotripter for mini and standard PCNL
verfasst von
Ravindra B. Sabnis
Sudharsan S. Balaji
Parag L. Sonawane
Rohan Sharma
Mohankumar Vijayakumar
Abhishek G. Singh
Arvind P. Ganpule
Mahesh R. Desai
Publikationsdatum
08.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02843-2

Weitere Artikel der Ausgabe 4/2020

World Journal of Urology 4/2020 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.